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SUMMARY  
 
From March 1984 to April 1991, the Orthopaedics Department of the Clínica 
Universitaria de Navarra treated 47 cases of malignant bone tumors in young children 
by limb-salvage surgery. Mean follow-up time was 4.4 years. The histologic diagnoses 
were osteosarcoma (33 cases) and Ewing's sarcoma (14 cases). All patients were treated 
following the Cancer Protocol of the Clínica Universitaria de Navarra. We used 
allograft reconstruction in 26 patients, autograft reconstruction in seven, and 
nonbiologic material in seven other patients. Thirty-six of these patients are alive 
currently; 11 have died. The overall survival rate was 76.6%. Three patients suffered 
local recurrences, and seven developed metastatic disease. The most significant 
complications were infection in four cases, and osteosynthesis anchorage detachment in 
eight cases. We believe that with recent medical, surgical, and rehabilitative advances, 
limb-salvage surgery has surpassed amputation as the primary treatment for malignant 
bone tumors in young children.  
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INTRODUCTION 
 
Primary malignant bone tumors occur in children (43). In about 75% of these patients, 
the lesions are located around the growth plate (30). Historically, these tumors have 
been treated by amputation (6). Only recently have more conservative procedures been 
practiced. The introduction of the new methods, namely diagnosis by image 
(25,28,31,35,45,52, 56) and use of preoperative chemotherapy (2,3,33, 39,42,44,47-49), 
contributed to indications for limb salvage. An increasing interest in limb-reconstruction 
techniques after resections has thus developed (1,4,8,9-12,14,15,17-
22,24,26,27,29,32,3638,40,41,46,51). 
 
Lesions occur most commonly in the lower limbs. The orthopedist must consider the 
eventual functional status resulting from the secondary deformity, which is predicted by 
the amount of removed physeal cartilage, when selecting a method of reconstruction. 
Our aim was to evaluate survival, functional results, and complications in patients 
treated with limb salvage instead of amputation. 
 
 
MATERIALS AND METHODS 
 
Patients treated for high-grade bone sarcomas from March 1984 to April 1991 were 
analyzed. Only patients who had a follow-up of ≥1 year were included in the study. Of 
the 47 patients, 21 were boys and 26 were girls. Average age was 11.6 years (range, 4-
15 years). Histologic diagnosis was osteosarcoma in 33 cases and Ewing's sarcoma in 
14. The anatomic cites of the lesions included 26 in the femur (three proximal, 10 mid-
diaphyseal, 13 distal), 15 in the tibia (11 proximal, one mid-diaphyseal, 3 distal), three 
in the humerus, two in the fibula, and one in the radius. Clinical data are given in Table 
1. 
 
All the patients were treated following the Cancer Protocol of the Clínica Universitaria 
de Navarra (7) (Table 2). (Surgical treatments are listed in Table 3.) The length of 
resection was 16.3 cm (range 10-34 cm). 
 
 
RESULTS 
 
Thirty-two of the 47 observed patients (68%) were alive and disease free after an 
average follow-up period of 53 months (minimum 12 months; maximum 96 months). 
Another 8.5% were alive with disease (6.4% with metastases and 2.1% with local 
recurrence). The remaining 23.4% died from metastases or local recurrence (14.9%), 
aplasia (6.4%), and leukemia (2.1%). 
 
Functional results were obtained using the classification adopted from the MSTS (23). 
Four cases (8.5%) involved the shoulder girdle or the upper extremity, and 43 (91.5%) 
involved the pelvic girdle or lower extremity. In proximal humerus resections, 
functional results were good in 50% of the cases (Fig. 1). In proximal femoral 
resections, reconstruction was accomplished with prostheses in all cases (Fig. 2); 66% 
of the cases had good results. One patient underwent Chiari osteotomy because he 
presented with a subluxans prosthesis. In the femoral and tibial diaphyseal resections, 
the results were excellent or good in 65% of the cases (Figs. 3-5). 
In knee resections, 15 were treated with a GSB prosthesis (Fig. 6), and three received an 
osteoarticular allograft. Seventy percent of those treated with prosthesis had excellent or 
good functional results. Patients treated with osteoarticular allograft had poor results. 
 
The most significant complications were infection in four cases (8.5%) and 
osteosynthesis anchorage detachment in eight cases (17%) (Fig. 7). The deep infections 
were treated by removal of the infected allograft. Limb length was maintained either by 
an antibiotic-impregnated polymethylmethacrylate spacer (Gentamicin-PMMA beads) 
or by bone cement with gentamicin (13) and external fixation. Antibiotics were then 
administered for 1-3 months; a new allograft was implanted in two patients. Gram-
positive organisms were the most common cause of infection. The delayed unions were 
treated by new reosteosynthesis plus autograft bone. Seven patients presented with 
limb-length discrepancies. These length inequalities resulted in growth recurrence in 
these patients. They were treated by limb lengthening (16) (Fig. 8). 
 
 
DISCUSSION 
 
Over the past several decades, there has been increased enthusiasm for limb-salvage 
surgery as a result of the improvements in the effectiveness of chemotherapy, better 
tumor imaging, and technical advancements in reconstructive surgery. Recent evidence 
suggests that excellent local tumor control can be achieved with preservation of 
function. Harris et al. (32) studied limb-salvage patients and compared them 
functionally with patients who had undergone amputation. Their study found 
comparable functional results between the two groups, but better emotional acceptance 
among limb-salvage patients. The local recurrence rate for limb salvage is similar to that 
for above-the-knee amputations (50). Survival rates are also comparable (50). 
 
Limb salvage is actually two separate operative procedures: the first involves tumor 
excision; its adequacy can be judged simply by the rate of local recurrence. The second 
procedure is reconstruction. There have been many recent reports in which various 
forms of reconstruction after limb salvage were reviewed (1,4,8,9-12,14,15,17-
22,24,26,27,29, 32,36-38,40,41,51). These procedures include prosthetic replacement, 
osteoarticular allograft arthroplasty, allograft—prosthetic composite arthroplasty, and 
arthrodesis. These reconstructive alternatives are currently being vetted for durability, 
function, and morbidity. We believe that the type of reconstruction used should be 
based on the individual patient's age, size, functional demands, and desires; the 
surgeon's experience should also be a factor. 
 
Resections requiring reconstruction can be subdivided into two major categories: 
diaphyseal resections and articular resections. We think that bone intercalary grafts are 
the proper treatment for diaphyseal resections. In these cases, allografts represent the 
ideal solution. We used the physeal distraction [Cañadell technique (8)] in 12 of our 
patients. At present, it is not completely clear what role chemotherapy plays with 
respect to the incorporation of bone grafts. There are various reports in the literature that 
give opposing viewpoints on the inhibition of osteogenesis from cytotoxic medications. 
These medications only slightly reduce the recipient's osteogenesis and the union of the 
graft (27). 
 
Articular resections represent the most complex reconstruction problem in oncologic 
surgery. Three forms of arthroplasty are used, namely prosthetic, osteoarticular 
allograft, and allograft—prosthetic composite arthroplasty. Prosthetic arthroplasty re-
places bone and joint with a metallic implant along with a polyethylene articulation. 
The constraint of the device is determined by the amount of soft tissue resection, and 
can range from resurfacing arthroplasty to hinge prosthesis. The advantage of prosthetic 
arthroplasty after tumor excision is ease of insertion and good short-term functional 
results. Its durability is uncertain, however. 
 
Osteoarticular allograft arthroplasty is a purely biologic solution to the replacement of 
bone and joint after en bloc tumor excision. This procedure replaces bone stock, and 
soft-tissue attachment to the allograft is possible. The drawbacks with this technique 
include articular degeneration, fracture, nonunion, and unstable joints. 
 
The newest reconstructive procedure to receive attention is the combination of a 
prosthetic arthroplasty with allograft bone replacement (9,10,12). This type of 
arthroplasty may diminish some of the previously mentioned problems. It is a technique 
that combines an allograft with an off-the-shelf arthroplasty, thus eliminating the need 
for custom prosthetic manufacturing and articular degeneration, and allowing for soft-
tissue attachment. Cara et al. (10) and Johnson and Mankin (34) described this 
technique as well as its indications, and, in our own experience, prosthetic arthroplasty 
with allograft has yielded a lower incidence of complication and better functional results 
than osteoarticular allograft arthroplasty. 
 
Arthrodeses are particularly indicated in surgery of the lower extremity. We use this 
technique principally in tumors localized in the distal tibia. Of considerable importance 
is the asymmetry at the end of growth, which might be severe enough to eliminate most 
of the advantages of preserving joint motion. This problem is obviously more serious in 
lower-extremity reconstruction. In the upper limb, severe asymmetry of up to 8-10 cm 
can be tolerated. In the lower extremity, several procedures have been described that 
show potential application in children. 
 
The first of these procedures is the Van Ness rotation plasty for sarcomas of the 
extremity. This procedure preserves the ankle and rotates the limb 180°, placing the 
ankle at the anatomic knee-joint level. The limb can be fitted as a below-the-knee 
amputation with greatly improved function (5). Another technique is the use of an 
expandable prosthesis for children who have significant growth potential. These devices 
are implanted after en bloc resection, and allow for further lengthening of the device as 
the child grows (36). Long-term durability of this device remains suspect. 
 
Our experience with bone lengthening in children leads us to believe that this technique 
is the most physiological reconstruction; sometimes, a contra-lateral epiphysiodesis is 
performed to maintain symmetry at the end of growth. 
 
All these techniques continue to have a high complication rate. The significant and 
sometimes unavoidable complications include mechanical failure of the implant, 
pseudarthrosis at the bone site, and infection. Infection is a particularly troublesome 
complication with allografts (13). The infection rate appears to be relatively low and 
comparable to other reconstructive procedures. Tomford et al. (54,55) reviewed their 
experience with allografts for tumor reconstruction and found a relatively low incidence 
of infection, and none that could be attributed to graft contamination during 
procurement. In our series, the incidente was 8.5%, which was similar to that found in 
other studies (19,41,53,55). 
 
The refinement of limb-salvage techniques has opened a new chapter in oncologic 
surgery of the musculoskeletal system, namely the ability to reconstruct the limb after 
surgical failures. 
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 Table 1. Clinical data 
Case Age Sex Location Histology Stage Treatment Survival Complications 
1 14 F Femur Osteosarcoma IIB KP + nBM Dead Toxicity
2 13 M Femur Osteosarcoma IIB KP + nBM Free ―
3 14 M Femur Ewing III HP Dead ―
4 10 F Femur Osteosarcoma III KP + nBM Dead ―
5 7 M Femur Osteosarcoma IIB Int Allo Free Bone length
6 15 M Femur Osteosarcoma IIB KP + nBM Free Replacement
7 13 M Tibia Ewing IIB KP + nBM Dead Nerve Palse
8 15 F Femur Osteosarcoma IIB Int Auto Free ―
9 13 F Femur Osteosarcoma IIB Int Auto Free Bone length
10 4 M Fibula Ewing IIB Int Auto Free ―
11 14 M Femur Osteosarcoma IIB Int Auto Free Delay Ost
12 14 F Femur Osteosarcoma IIB KP + Allo Free Delay Ost
13 8 F Tibia Ewing IIB Int Auto Free Bone length
14 12 F Tibia Osteosarcoma IIB KP + nBM Dead ―
15 11 M Tibia Ewing IIB Int Auto Free Delay Ost
16 11 M Humerus Ewing IIB Int Allo Free ―
17 10 F Tibia Osteosarcoma IIB Int Allo Disease Local recurrence
18 10 F Femur Osteosarcoma IIB Int Allo Free ―
19 13 F Tibia Osteosarcoma IIB KP + nBM Free ―
20 13 M Femur Ewing IIB Int Allo Dead Toxicity
21 9 F Tibia Ewing IIB Int Allo Free ―
22 15 F Tibia Osteosarcoma IIB KP + Allo Free ―
23 15 F Femur Osteosarcoma III Ost Allo Disease ―
24 13 F Femur Osteosarcoma IIB KP + Allo Free ―
25 13 F Femur Osteosarcoma IIB Int Allo Free ―
26 8 M Humerus Osteosarcoma IIB SP Dead ―
27 7 F Femur Osteosarcoma IIB HP Disease Bone length
28 14 F Humerus Osteosarcoma IIB Ost Allo Free ―
29 13 M Fibula Ewing IIB Resection Free ―
30 14 F Tibia Osteosarcoma IIB KP + Allo Free Delay Ost
31 10 M Femur Osteosarcoma III Ost Allo Free Bone length
32 15 F Femur Osteosarcoma IIB Int Allo Disease Delay Ost
33 9 M Femur Osteosarcoma IIB Ost Allo Free Infection
     Bone length
34 8 M Femur Ewing IIB HP Free Bone length
35 15 M Femur Osteosarcoma IIB Int Allo Free Infection
36 9 F Femur Osteosarcoma IIB Int Allo Dead Leukemia
37 9 F Radio Ewing III Resection Dead ―
38 11 F Femur Osteosarcoma IIB Int Allo Free ―
39 14 F Tibia Osteosarcoma IIB KP + Allo Dead Infection
40 14 F Tibia Osteosarcoma IIB Int Allo Free ―
41 11 M Tibia Ewing IIB KP + Allo Free Infection
42 11 M Tibia Osteosarcoma IIB Int Allo Free Delay Ost
43 13 F Tibia Ewing IIB KP + Allo Dead Toxicity
44 15 F Tibia Osteosarcoma IIB KP + Allo Free ―
45 14 M Femur Osteosarcoma IIB Int Allo Free Delay Ost
46 15 M Femur Osteosarcoma IIB Int Allo Free Delay Ost
47 10 M Femur Ewing IIB HP Free ―
KP, Knee prosthesis; HP, hip prosthesis; SP, Shoulder prosthesis; nBM, nonbiologic material; 
Allo, allograft; Auto, autograft; Int, intercalar; Ost, osteoarticular. 
 Table 2. Protocol used in treatment 
Osteosarcoma 
Neoadjuvant chemotherapy (i.a. + i.v.) 
Surgery + IOR 
Postoperative chemotherapy (i.v.) 
Ewing's sarcoma 
Preoperative chemotherapy (i.v.) + Radiotherapy 
Surgery + IOR 
Postoperative chemotherapy (i.v.) 
i.a., intraarterial; i.v., intravenous; IOR, intraoperative radiotherapy. 
 
 
 
 
 
 
 
Table 3. Surgical treatment according to site 
Treatment No. of cases 
Prosthesis  
Hip 4 
Knee  
Allograft 8 
Nonbiologic material 7 
Intercalary graft  
Allograft 12 
Autograft 7 
Arthrodesis  
Allograft 2 
Osteoarticular graft  
Allograft 2 
Resection 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Preoperative anteroposterior radiograph of Ewing's sarcoma of the proximal 
one-third of the right humerus, and postoperative control after resection and 
replacement with an endoprosthesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. An 11-year-old boy with Ewing's sarcoma treated with endoprosthesis for the 
hip joint. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. A and B: Functional aspect after a conservative surgery of the extremity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. A 10-year-old girl affected with osteosarcoma of the distal femur (A). She 
was treated while performing physeal distraction. The segment was removed en bloc, 
and an intercalary bone graft was performed (B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Roentgenogram of an 8-year-old girl affected with Ewing's sarcoma of the 
proximal tibia (A). We resected the tumor and effected reconstruction with an 
intercalary bone allograft (B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Osteosarcoma of the distal femur; radiological appearance after consolidation. 
  
Figure 7. A: Osteosarcoma at the middle femur. B: Allograft replacement after tumoral 
en bloc resection, and fixation with a condylar plate and a DCP plate. C: Osteosynthesis 
anchorage detachment. D: Fixation with a DHS plate shows consolidation 6 months 
later. 
 
 
 
 
Figure 8. A and B: Radiographs taken during lengthening period show technique using 
an external fixation with three pin holders and a proximal metaphyseal osteotomy. C: 
Final result after lengthening. 
